1,7-phenanthroline has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alvestad Linger, RM; Browning, MD; Davies, KD; Freund, RK; Goebel-Goody, SM | 1 |
Prosser, RA; Yamada, Y | 1 |
2 other study(ies) available for 1,7-phenanthroline and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
Article | Year |
---|---|
Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices.
Topics: Animals; Bicuculline; Biophysical Phenomena; Excitatory Postsynaptic Potentials; GABA Antagonists; Glutamic Acid; Hippocampus; Immunoprecipitation; In Vitro Techniques; Male; Neuronal Plasticity; Neurons; Organometallic Compounds; Patch-Clamp Techniques; Phenanthrolines; Phosphorylation; Protein Subunits; Protein Transport; Protein Tyrosine Phosphatases; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Subcellular Fractions; Synapses; Tyrosine | 2009 |
Copper chelation and exogenous copper affect circadian clock phase resetting in the suprachiasmatic nucleus in vitro.
Topics: Animals; Carbazoles; Chelating Agents; Circadian Clocks; Copper; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Glutamic Acid; In Vitro Techniques; Indole Alkaloids; Male; Mice; Mice, Inbred C57BL; Molybdenum; Phenanthrolines; Quinoxalines; Suprachiasmatic Nucleus; Valine | 2014 |